Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Common Equity (2020 - 2025)

Trulieve Cannabis has reported Common Equity over the past 6 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put Common Equity at $1.1 billion for Q4 2025, down 8.49% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (down 8.49% YoY), and the annual figure for FY2025 was $1.1 billion, down 8.49%.
  • Common Equity for Q4 2025 was $1.1 billion at Trulieve Cannabis, down from $1.2 billion in the prior quarter.
  • Over the last five years, Common Equity for TCNNF hit a ceiling of $2.1 billion in Q4 2021 and a floor of $485.6 million in Q1 2021.
  • Median Common Equity over the past 5 years was $1.4 billion (2024), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Common Equity: skyrocketed 379.43% in 2021 and later tumbled 31.04% in 2023.
  • Trulieve Cannabis' Common Equity stood at $2.1 billion in 2021, then dropped by 10.23% to $1.9 billion in 2022, then dropped by 26.93% to $1.4 billion in 2023, then fell by 11.33% to $1.2 billion in 2024, then fell by 8.49% to $1.1 billion in 2025.
  • The last three reported values for Common Equity were $1.1 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025) per Business Quant data.